Atlas Trials

Vandetanib, Oxaliplatin, and Docetaxel in Advanced Cancer of the Esophagus or Gastroesophageal Junction

Clinical trial NCT00732745 · TERMINATED

Trial details

NCT number
NCT00732745
Sponsor
Case Comprehensive Cancer Center
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Adenocarcinoma of the Gastroesophageal JunctionEsophageal Cancer
Start date
2008-10-01
Primary completion
2010-06-01
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.